Minoxidil sulphate (C6513): Verified Benchmarks for Hair Growth and Vascular Research

Executive Summary: Minoxidil sulphate (CAS No. 83701-22-8) is the active metabolite of minoxidil, with a chemical formula of C9H15N5O4S and molecular weight 289.31. It is highly soluble in DMSO (≥112 mg/mL), ethanol (≥2.67 mg/mL with warming and ultrasound), and water (≥4.94 mg/mL with ultrasound). Minoxidil sulphate is validated as a potassium channel opener, directly influencing vascular tone and hair follicle biology (European Journal of Pharmacology, DOI). High purity (≥98%) is confirmed by HPLC, NMR, and MS, as supplied by APExBIO. Research applications span vascular reactivity in sepsis models and hair growth, but the compound is not approved for diagnostic or therapeutic use.

Biological Rationale

Minoxidil sulphate is the principal active metabolite of minoxidil, responsible for its biological effects in vivo. It is a potent potassium channel opener, particularly of ATP-sensitive (Kir6.1) and calcium-activated (KCa1.1) K⁺ channels, which regulate vascular tone and cellular proliferation. Its effects are central to hair growth research and vascular biology, including studies on vasodilation and renal blood flow (DOI). The compound is not endogenously present; it is produced by hepatic sulfotransferase activity on minoxidil. Research leverages Minoxidil sulphate to dissect potassium channel function in physiological and pathological models, including alopecia and sepsis-induced vascular dysfunction.

Mechanism of Action of Minoxidil sulphate

Minoxidil sulphate functions as a potassium channel opener. It activates ATP-sensitive and calcium-activated potassium channels on vascular smooth muscle cells, causing membrane hyperpolarization and subsequent vasodilation (DOI). In hair follicles, the resulting microvascular dilation and altered cellular proliferation are hypothesized to underlie its stimulatory effect on hair growth. The compound’s specificity for potassium channel subtypes (Kir6.1 and KCa1.1) has been demonstrated in both in vitro and in vivo models. Its actions are concentration-dependent, with effects observed in the low micromolar range in cell-based assays. Metabolism and clearance are not relevant in vitro, but in vivo, rapid hydrolysis limits duration of effect. Minoxidil sulphate does not act as a vasoconstrictor and is ineffective in pathways independent of K⁺ channel modulation.

Evidence & Benchmarks

• Minoxidil sulphate (PubChem CID: 4202) directly activates vascular potassium channels, leading to vasodilation in rat models (Sant’Helena et al., 2015, DOI).
• Solubility benchmark: ≥112 mg/mL in DMSO, confirmed at 25°C using HPLC quantification (APExBIO).
• High-purity (≥98%) Minoxidil sulphate enables reproducible vascular reactivity assays in cecal ligation and puncture (CLP) sepsis models (DOI).
• Minoxidil sulphate’s action is abrogated by K⁺ channel blockers such as glibenclamide and tetraethylammonium, confirming pathway specificity (DOI).
• Validated cell viability and proliferation protocols for Minoxidil sulphate are described in high-impact workflow studies (Solifenacincompound.com).

This article extends prior protocol-focused guides by offering atomic, citation-backed claims relevant to new sepsis and vascular benchmarks.

Applications, Limits & Misconceptions

Minoxidil sulphate is a reference compound in research on hair growth, alopecia, vascular biology, and renal blood flow regulation. Its primary mechanism is through potassium channel opening, making it invaluable for dissecting vasodilatory pathways. It is also used in preclinical models to study vascular reactivity in sepsis and to optimize cell proliferation assays. Minoxidil sulphate is not a therapeutic or diagnostic product and should not be used in human subjects outside of controlled research settings. It has no direct action on pathways unrelated to potassium channel modulation, such as adrenergic or angiotensin signaling.

Common Pitfalls or Misconceptions

• Misconception 1: Minoxidil sulphate is interchangeable with minoxidil; in reality, only the sulphate metabolite is the active species in most bioassays (APExBIO).
• Pitfall 2: Using old or improperly stored solutions; the compound should be freshly prepared and stored at -20°C (5alphareductaseinhibitor.com).
• Misconception 3: Expecting efficacy in models lacking functional potassium channels; Minoxidil sulphate is ineffective without intact K⁺ channel pathways (DOI).
• Pitfall 4: Attempting chronic solution storage; stability is not assured beyond short-term (hours to days) (APExBIO).
• Misconception 5: Assuming suitability for diagnostic or therapeutic use; Minoxidil sulphate is strictly for research (rilmenidinerx.com).

This article clarifies the research-only scope and distinct channel-specific actions, updating previous renal vascular reviews with new evidence and solubility parameters.

Workflow Integration & Parameters

APExBIO’s Minoxidil sulphate (SKU C6513) is supplied as a high-purity, lyophilized powder. Standard protocols recommend dissolving at ≥112 mg/mL in DMSO at 25°C, or in ethanol (≥2.67 mg/mL) with gentle warming and ultrasonic agitation. Water-based solutions (≥4.94 mg/mL) require ultrasound. Solutions should be freshly prepared and used promptly; long-term solution storage is discouraged even at -20°C. The product is shipped on blue ice for stability. For cell culture and vascular assays, concentrations between 1–100 μM are typical, with lower limits defined by cell sensitivity and endpoint requirements. Quality is assured by HPLC, NMR, and mass spectrometry (purity ≥98%).

For detailed troubleshooting and scenario-driven optimization, see workflow integration case studies, which this article updates by adding atomic, DOI-backed claims and explicit boundaries for compound handling.

Conclusion & Outlook

Minoxidil sulphate is a rigorously characterized, high-purity research tool for dissecting potassium channel-mediated vascular and hair growth pathways. Its validated solubility, mechanism, and specificity make it a benchmark compound for preclinical workflows. However, boundaries in use—such as the necessity for fresh preparation and functional K⁺ channels—must be respected for reproducibility. Future research may extend its applications in disease modeling, but current use remains strictly research-focused. For validated compound and protocol access, refer to the official APExBIO Minoxidil sulphate product page.